No Picture
News

Regulus Therapeutics Announces Receipt of $5 Million Milestone and Material Payments from Sanofi

Proceeds Used to Repay Debt Principal with Oxford Finance

LA JOLLA, Calif., Oct. 13, 2020 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS) (the “Company” or “Regulus”), a biopharmaceutical company focused on the discovery and development of i… […]